Evaluating Pharmacogenetic Tests | Zendy

Carol L. Freund | Zendy; David F. Gregory | Zendy; Ellen Wright Clayton | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluating Pharmacogenetic Tests

Author(s) -

Carol L. Freund,

David F. Gregory,

Ellen Wright Clayton

Publication year - 2004

Publication title -

archives of pediatrics and adolescent medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3628

pISSN - 1072-4710

DOI - 10.1001/archpedi.158.3.276

Subject(s) - pharmacogenetics , affect (linguistics) , value (mathematics) , medicine , psychology , intensive care medicine , risk analysis (engineering) , computer science , gene , biology , genetics , genotype , machine learning , communication

Work in human genetics is revealing genes that affect the safe and effective use of pharmaceuticals. Primary care physicians are already receiving advertisements for tests for these variations that emphasize the value of learning about their patients' susceptibility to adverse reactions in order to avoid them. We propose a strategy for the critical evaluation of such offers to ensure the optimal use of these tests.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research